Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic

H Kalister1, R D Newman, L Read

  • 1School of Pharmacy, University of Washington, and the Harborview Medical Center, Seattle 98118, USA.

Insights

Pharmacists can safely evaluate and treat minor pediatric illnesses, improving access to care for underserved immigrant families. This new service offers prompt attention and bilingual education, showing high parent satisfaction.

Area of Science:

  • Pediatric Health
  • Clinical Pharmacy Services
  • Health Disparities

Background:

  • Medically underserved immigrant parents face barriers accessing treatments for childhood illnesses.
  • Limited financial resources and language barriers restrict home treatment options.

Purpose of the Study:

  • To establish a clinical service in an urban pediatric clinic for pharmacists to treat minor acute illnesses in children and adolescents.
  • To provide bilingual patient education materials to a diverse immigrant population.

Main Methods:

  • Developed protocols for pharmacist evaluation of 5 common pediatric conditions.
  • Created bilingual patient education materials in 8 languages.
  • Assessed safety via medical record review and parent telephone surveys.

Main Results:

  • 191 pediatric patients were evaluated and treated, primarily for cough/cold (76%).
  • 70% of patients were immigrants; no adverse outcomes were detected.
  • High parent satisfaction, prompt service (<15-min wait), and written information were reported.

Conclusions:

  • Pharmacist-led evaluation and treatment of minor pediatric illnesses is safe and well-received.
  • This service can enhance access to care, particularly for immigrant children.
  • Further research on cost-effectiveness in various settings is recommended.
Abstract

Related Concept Videos

Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...